Amdocs Competitors

Amdocs (NASDAQ:DOX) and Accenture (NYSE:ACN) are both large-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares Amdocs and Accenture's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Amdocs and Accenture's top-line revenue, earnings per share (EPS) and valuation.

Accenture has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

89.0% of Amdocs shares are held by institutional investors. Comparatively, 71.0% of Accenture shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 0.1% of Accenture shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for Amdocs and Accenture, as provided by MarketBeat.com.

Amdocs currently has a consensus price target of $82.00, indicating a potential upside of 8.18%. Accenture has a consensus price target of $253.0417, indicating a potential upside of 0.33%. Given Amdocs' stronger consensus rating and higher possible upside, equities research analysts plainly believe Amdocs is more favorable than Accenture.

Dividends

Amdocs pays an annual dividend of $1.31 per share and has a dividend yield of 1.7%. Accenture pays an annual dividend of $3.52 per share and has a dividend yield of 1.4%. Amdocs pays out 31.3% of its earnings in the form of a dividend. Accenture pays out 47.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 7 consecutive years and Accenture has increased its dividend for 1 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk and Volatility

Amdocs has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Accenture has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.

Summary

Accenture beats Amdocs on 9 of the 17 factors compared between the two stocks.

Amdocs (NASDAQ:DOX) and International Business Machines (NYSE:IBM) are both large-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares Amdocs and International Business Machines' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Amdocs and International Business Machines' top-line revenue, earnings per share (EPS) and valuation.

International Business Machines has higher revenue and earnings than Amdocs. International Business Machines is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

89.0% of Amdocs shares are held by institutional investors. Comparatively, 55.7% of International Business Machines shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 0.2% of International Business Machines shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for Amdocs and International Business Machines, as provided by MarketBeat.com.

Amdocs currently has a consensus price target of $82.00, indicating a potential upside of 8.18%. International Business Machines has a consensus price target of $139.8462, indicating a potential upside of 16.52%. Given International Business Machines' higher possible upside, analysts plainly believe International Business Machines is more favorable than Amdocs.

Dividends

Amdocs pays an annual dividend of $1.31 per share and has a dividend yield of 1.7%. International Business Machines pays an annual dividend of $6.52 per share and has a dividend yield of 5.4%. Amdocs pays out 31.3% of its earnings in the form of a dividend. International Business Machines pays out 50.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 7 consecutive years and International Business Machines has increased its dividend for 21 consecutive years. International Business Machines is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk and Volatility

Amdocs has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, International Business Machines has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500.

Summary

International Business Machines beats Amdocs on 9 of the 17 factors compared between the two stocks.

Amdocs (NASDAQ:DOX) and Cognizant Technology Solutions (NASDAQ:CTSH) are both large-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares Amdocs and Cognizant Technology Solutions' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Amdocs and Cognizant Technology Solutions' top-line revenue, earnings per share (EPS) and valuation.

Cognizant Technology Solutions has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Cognizant Technology Solutions, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

89.0% of Amdocs shares are held by institutional investors. Comparatively, 87.7% of Cognizant Technology Solutions shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 0.3% of Cognizant Technology Solutions shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for Amdocs and Cognizant Technology Solutions, as provided by MarketBeat.com.

Amdocs currently has a consensus price target of $82.00, indicating a potential upside of 8.18%. Cognizant Technology Solutions has a consensus price target of $77.9048, indicating a potential upside of 6.53%. Given Amdocs' stronger consensus rating and higher possible upside, equities research analysts plainly believe Amdocs is more favorable than Cognizant Technology Solutions.

Dividends

Amdocs pays an annual dividend of $1.31 per share and has a dividend yield of 1.7%. Cognizant Technology Solutions pays an annual dividend of $0.96 per share and has a dividend yield of 1.3%. Amdocs pays out 31.3% of its earnings in the form of a dividend. Cognizant Technology Solutions pays out 24.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 7 consecutive years and Cognizant Technology Solutions has increased its dividend for 1 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk and Volatility

Amdocs has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Cognizant Technology Solutions has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.

Summary

Amdocs beats Cognizant Technology Solutions on 9 of the 17 factors compared between the two stocks.

Amdocs (NASDAQ:DOX) and EPAM Systems (NYSE:EPAM) are both large-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends.

Analyst Recommendations

This is a summary of recent ratings and price targets for Amdocs and EPAM Systems, as provided by MarketBeat.com.

Amdocs currently has a consensus price target of $82.00, indicating a potential upside of 8.18%. EPAM Systems has a consensus price target of $363.3077, indicating a potential upside of 0.36%. Given Amdocs' stronger consensus rating and higher possible upside, equities research analysts plainly believe Amdocs is more favorable than EPAM Systems.

Profitability

This table compares Amdocs and EPAM Systems' net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Amdocs and EPAM Systems' gross revenue, earnings per share and valuation.

Amdocs has higher revenue and earnings than EPAM Systems. Amdocs is trading at a lower price-to-earnings ratio than EPAM Systems, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Amdocs has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Comparatively, EPAM Systems has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500.

Institutional and Insider Ownership

89.0% of Amdocs shares are held by institutional investors. Comparatively, 92.0% of EPAM Systems shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 4.8% of EPAM Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

EPAM Systems beats Amdocs on 9 of the 14 factors compared between the two stocks.

Gartner (NYSE:IT) and Amdocs (NASDAQ:DOX) are both large-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, valuation and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Gartner and Amdocs, as provided by MarketBeat.

Gartner currently has a consensus price target of $168.1667, indicating a potential downside of 6.25%. Amdocs has a consensus price target of $82.00, indicating a potential upside of 8.18%. Given Amdocs' stronger consensus rating and higher possible upside, analysts clearly believe Amdocs is more favorable than Gartner.

Profitability

This table compares Gartner and Amdocs' net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Gartner and Amdocs' revenue, earnings per share (EPS) and valuation.

Amdocs has lower revenue, but higher earnings than Gartner. Amdocs is trading at a lower price-to-earnings ratio than Gartner, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Gartner has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500. Comparatively, Amdocs has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500.

Institutional & Insider Ownership

92.3% of Gartner shares are owned by institutional investors. Comparatively, 89.0% of Amdocs shares are owned by institutional investors. 4.0% of Gartner shares are owned by company insiders. Comparatively, 15.4% of Amdocs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Amdocs beats Gartner on 7 of the 13 factors compared between the two stocks.

Leidos (NYSE:LDOS) and Amdocs (NASDAQ:DOX) are both large-cap aerospace companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, valuation and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Leidos and Amdocs, as provided by MarketBeat.

Leidos currently has a consensus price target of $116.3636, indicating a potential upside of 28.92%. Amdocs has a consensus price target of $82.00, indicating a potential upside of 8.18%. Given Leidos' higher possible upside, research analysts clearly believe Leidos is more favorable than Amdocs.

Profitability

This table compares Leidos and Amdocs' net margins, return on equity and return on assets.

Dividends

Leidos pays an annual dividend of $1.36 per share and has a dividend yield of 1.5%. Amdocs pays an annual dividend of $1.31 per share and has a dividend yield of 1.7%. Leidos pays out 26.3% of its earnings in the form of a dividend. Amdocs pays out 31.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Leidos has raised its dividend for 1 consecutive years and Amdocs has raised its dividend for 7 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Valuation & Earnings

This table compares Leidos and Amdocs' top-line revenue, earnings per share (EPS) and valuation.

Leidos has higher revenue and earnings than Amdocs. Leidos is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Leidos has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Comparatively, Amdocs has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500.

Institutional & Insider Ownership

74.2% of Leidos shares are owned by institutional investors. Comparatively, 89.0% of Amdocs shares are owned by institutional investors. 1.5% of Leidos shares are owned by insiders. Comparatively, 15.4% of Amdocs shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Leidos beats Amdocs on 9 of the 17 factors compared between the two stocks.